In Vitro Susceptibility to Ceftazidime/Avibactam and Comparators in Clinical Isolates of Enterobacterales from Five Latin American Countries | ||
| dc.conicet.organizacion | Universidad El Bosque | |
| dc.conicet.organizacion | Universidad El Bosque | |
| dc.conicet.organizacion | Universidad El Bosque | |
| dc.conicet.organizacion | Universidad El Bosque | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Microbiología, Inmunología y Biotecnología. Cátedra de Microbiología | |
| dc.conicet.organizacion | Hospital Médica Sur | |
| dc.conicet.organizacion | Hospital San Angel | |
| dc.conicet.organizacion | Universidade de Sao Paulo | |
| dc.conicet.organizacion | No especifíca | |
| dc.conicet.organizacion | Universidad El Bosque | |
| dc.contributor.author | Appel, Tobias Manuel | |
| dc.contributor.author | Mojica, Maria Fernanda | |
| dc.contributor.author | De La Cadena, Elsa | |
| dc.contributor.author | Pallares, Cristian | |
| dc.contributor.author | Radice, Marcela Alejandra | |
| dc.contributor.author | Castañeda Méndez, Paulo | |
| dc.contributor.author | Jaime-Villalón, Diego | |
| dc.contributor.author | Gales, Ana | |
| dc.contributor.author | Munita, Jose | |
| dc.contributor.author | Villegas, Maria | |
| dc.date.issued | 2020-02 | |
| dc.description.abstract | Background: High rates of resistance to third-generation cephalosporins and carbapenems in Enterobacterales have been reported in Latin America. Ceftazidime/avibactam (CZA) is the combination of a third-generation cephalosporin and a non-β-lactam β-lactamase inhibitor, which hasshown activity against isolates producing class A, C and D β-lactamases. Herein, we evaluated the activity of CZA and comparators against clinical isolates of Enterobacterales in Latin America. Methods: The activity of CZA and comparators was evaluated against clinical isolates of Enterobacterales from Argentina, Brazil, Chile, Colombia and Mexico that were collected between January 2016 andOctober 2017. One specific phenotypic subset was evaluated. A carbapenem non-susceptible (CNS) phenotype was defined as any isolate displaying a minimum inhibitory concentration (MIC) ≥1 mg/L for ertapenem. Results: CZA was active against 95.8% of all isolates and 77.5% of CNS isolates. Fosfomycin (FOS) and tigecycline (TGC) were the second most active antibiotics with 93.4% ofEnterobacterales being susceptible. Conclusions: The results of this study underline the potential therapeutic role of CZA in Latin America | es |
| dc.description.fil | Fil: Appel, Tobias Manuel. Universidad El Bosque; Colombia | |
| dc.description.fil | Fil: Mojica, Maria Fernanda. Universidad El Bosque; Colombia | |
| dc.description.fil | Fil: De La Cadena, Elsa. Universidad El Bosque; Colombia | |
| dc.description.fil | Fil: Pallares, Cristian. Universidad El Bosque; Colombia | |
| dc.description.fil | Fil: Radice, Marcela Alejandra. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Microbiología, Inmunología y Biotecnología. Cátedra de Microbiología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.description.fil | Fil: Castañeda Méndez, Paulo. Hospital Médica Sur; México | |
| dc.description.fil | Fil: Jaime-Villalón, Diego. Hospital San Angel; México | |
| dc.description.fil | Fil: Gales, Ana. Universidade de Sao Paulo; Brasil | |
| dc.description.fil | Fil: Munita, Jose. No especifíca; | |
| dc.description.fil | Fil: Villegas, Maria. Universidad El Bosque; Colombia | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Appel, Tobias Manuel; Mojica, Maria Fernanda; De La Cadena, Elsa; Pallares, Cristian; Radice, Marcela Alejandra; et al.; In Vitro Susceptibility to Ceftazidime/Avibactam and Comparators in Clinical Isolates of Enterobacterales from Five Latin American Countries; MDPI; Antibiotics; 9; 2; 2-2020; 1-7 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 2079-6382 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/109947 | |
| dc.journal.ciudad | Bassel | es |
| dc.journal.number | 2 | es |
| dc.journal.pagination | 1-7 | es |
| dc.journal.pais | Suiza | es |
| dc.journal.title | Antibiotics | es |
| dc.journal.volume | 9 | es |
| dc.language.iso | eng | es |
| dc.publisher | MDPI | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3390/antibiotics9020062 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/2079-6382/9/2/62 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | Ceftazidime/Avibactam | es |
| dc.subject | Enterobacterales | es |
| dc.subject | Antibiotic susceptibility | es |
| dc.subject.classification | Otras Ciencias de la Salud | es |
| dc.subject.classification | Ciencias de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | In Vitro Susceptibility to Ceftazidime/Avibactam and Comparators in Clinical Isolates of Enterobacterales from Five Latin American Countries | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.b98aa338-b99d-49dc-866d-8df938586647_A.pdf
- Tamaño:
- 225.75 KB
- Formato:
- Adobe Portable Document Format